Related Experiment Videos
[The immunological treatment of renal cancer]
J Tabernero Caturla1, R Salazar Soler, J L González Larriba
1Servicio de Oncologia Medica, Hospital de la Santa Creu i Sant Pau, Barcelona. tabernero@redestb.es
Medicina Clinica
|April 30, 1999
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy - results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2021
A randomized phase II/III study of cabazitaxel versus vinflunine in metastatic or locally advanced transitional cell carcinoma of the urothelium (SECAVIN).
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Validation of the International Metastatic Renal-Cell Carcinoma Database Consortium (IMDC) prognostic model for first-line pazopanib in metastatic renal carcinoma: the Spanish Oncologic Genitourinary Group (SOGUG) SPAZO study.
Annals of oncology : official journal of the European Society for Medical Oncology·2015
Breslow thickness and (18)F-FDG PET-CT result in initial staging of cutaneous melanoma: Can a cut-off point be established?
Revista espanola de medicina nuclear e imagen molecular·2015
New challenges in kidney cancer management: integration of surgery and novel therapies.
Current treatment options in oncology·2015
Cost-effectiveness evaluation of sunitinib as first-line targeted therapy for metastatic renal cell carcinoma in Spain.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2011
Tularemia: a re-emerging zoonosis.
Medicina clinica·2026
Complex regional pain syndrome and amputation.
Medicina clinica·2026